ReviewAsian journal of pharmaceutical sciences2023

Therapeutic potential of exosome-based personalized delivery platform in chronic inflammatory diseases.

Chenglong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.